Healthy Living/WellnessGilead Sciences' blockbuster $84k Hepatitis C drug has just made its CEO a billionaire Gilead's earnings generated mostly by its hepatitis C drug Sovaldi benefit its CEO John Martin as well, as he owns 4.2 million shares of the company.by Rhodilee Jean Dolor
Healthy Living/WellnessFacebook frequenters may be at higher risk of disordered eatingby Tabitha Laffernis
Healthy Living/WellnessThoratec issues warning about heart pump controller linked to four deathsby Tabitha Laffernis
Healthy Living/WellnessSomething fishy going on: bacterial infection linked to New York's Chinatown districtsby Tabitha Laffernis
Healthy Living/WellnessNew U.S. guidelines successful in making school kids eat more veggies and fruitsby Maryanne Moll
Healthy Living/WellnessTestosterone replacement drug Aveed gets the FDA's stamp of approvalby Tabitha Laffernis
Healthy Living/WellnessHepatitis C cases fall in the U.S. but it's not because of any cureby Rhodilee Jean Dolor
iPadOS Stage Manager Unlocks Powerful Multitasking, External Display Support, and Smart Window Management